Terms: = Breast cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L
686 results:
1. [Clinicopathological characteristics and immune microenvironment of breast squamous cell carcinoma].
Liang JY; Wang YM; Wen Z; Zhang WH; Gao ZZ; Wang Z; Guo SP
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):337-343. PubMed ID: 38556816
[No Abstract] [Full Text] [Related]
2. Case report: A case of Paget disease outside the axillary breast.
Zhou Z; Zhou B; Wu X; Wei W
Medicine (Baltimore); 2024 Mar; 103(13):e37541. PubMed ID: 38552095
[TBL] [Abstract] [Full Text] [Related]
3. Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of ΔNp63α expression and promote breast cancer metastasis independent of HIF1α.
Chen H; Yu S; Ma R; Deng L; Yi Y; Niu M; Xu C; Xiao ZJ
Cell Death Differ; 2024 Apr; 31(4):447-459. PubMed ID: 38413797
[TBL] [Abstract] [Full Text] [Related]
4. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
5. Spindle cell carcinoma of male breast: Report of a rare case.
Palo S; Jaiswal S
J Cancer Res Ther; 2023 Oct; 19(7):2067-2069. PubMed ID: 38376321
[TBL] [Abstract] [Full Text] [Related]
6. A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63.
Low-Calle AM; Ghoneima H; Ortega N; Cuibus AM; Katz C; Prives C; Prywes R
Mol Cell Biol; 2024 Jan; 44(1):27-42. PubMed ID: 38270135
[TBL] [Abstract] [Full Text] [Related]
7. Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1α.
Ren Z; Dharmaratne M; Liang H; Benard O; Morales-Gallego M; Suyama K; Kumar V; Fard AT; Kulkarni AS; Prystowsky M; Mar JC; Norton L; Hazan RB
Br J Cancer; 2024 Apr; 130(6):908-924. PubMed ID: 38238426
[TBL] [Abstract] [Full Text] [Related]
8. Pan-cancer analysis reveals the characteristics and roles of tooth agenesis mutant genes.
Liu Y; Yang J; Li X; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
Medicine (Baltimore); 2023 Dec; 102(50):e36001. PubMed ID: 38115305
[TBL] [Abstract] [Full Text] [Related]
9. Neoadjuvant pyrotinib plus trastuzumab and chemotherapy for HER2-positive breast cancer: a prospective cohort study.
Liu L; Zhu M; Wang Y; Li M; Gu Y
World J Surg Oncol; 2023 Dec; 21(1):389. PubMed ID: 38114991
[TBL] [Abstract] [Full Text] [Related]
10. Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic breast cancer.
Hamelin B; Obradović MMS; Sethi A; Kloc M; Münst S; Beisel C; Eschbach K; Kohler H; Soysal S; Vetter M; Weber WP; Stadler MB; Bentires-Alj M
J Mammary Gland Biol Neoplasia; 2023 Dec; 28(1):26. PubMed ID: 38066300
[TBL] [Abstract] [Full Text] [Related]
11. ΔNp63 is regulated by insulin/IGF-1 signaling in normal basal/progenitor mammary cells and in luminal-type breast cancer cells.
Stenckova M; Liu Y; Nekulova M; Holcakova J; Pokorna Z; Nenutil R; Thompson AM; Vojtesek B; Coates PJ
Neoplasma; 2023 Oct; 70(5):621-632. PubMed ID: 38053383
[TBL] [Abstract] [Full Text] [Related]
12. Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls.
Alkhayyat R; Abbas A; Quinn CM; Rakha EA
Histopathology; 2024 Apr; 84(5):723-741. PubMed ID: 38012539
[TBL] [Abstract] [Full Text] [Related]
13. Misleading images of ductal carcinoma in situ: 4 lymph nodes with metastasis.
Abecia Martínez EI; Sanromán AC; Leon L; Monge LS; Zarza BE
Rev Esp Patol; 2023; 56(4):252-260. PubMed ID: 37879822
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic analyses of genes associated with anoikis in breast cancer.
Cao J; Ma X; Zhang G; Hong S; Ma R; Wang Y; Yan X; Ma M
PeerJ; 2023; 11():e15475. PubMed ID: 37842046
[TBL] [Abstract] [Full Text] [Related]
15. Cell Block-Based Two-Dimensional and Immunocytochemical Analyses Could Reduce Atypical/Indeterminate Case Frequency in breast Fine-Needle Aspiration Cytology: A Retrospective Analysis.
Noda Y; Nakanishi Y; Tsuta K; Inaji H; Yamasaki M
Acta Cytol; 2023; 67(6):583-592. PubMed ID: 37820610
[TBL] [Abstract] [Full Text] [Related]
16. Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody.
Wang Y; Song X; Song Y; Fang K; Chang X
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17253-17268. PubMed ID: 37804426
[TBL] [Abstract] [Full Text] [Related]
17. [Clinicopathological analysis of benign mammary ductal cystic papillomatosis with loss of myoepithelial cells].
An R; Ma ZY; Zhu HY; Zhang LY; Li L; Wang C; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2023 Sep; 52(9):902-906. PubMed ID: 37670618
[No Abstract] [Full Text] [Related]
18. Solid-Basaloid Adenoid Cystic Carcinoma of the breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.
Shamir ER; Bean GR; Schwartz CJ; Vohra P; Wang A; Allard GM; Wolsky RJ; Garcia JJ; Chen YY; Krings G
Mod Pathol; 2023 Dec; 36(12):100324. PubMed ID: 37660928
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes.
Li Q; Liu H; Jin Y; Yu Y; Wang Y; Wu D; Guo Y; Xi L; Ye D; Pan Y; Zhang X; Li J
Comput Biol Med; 2023 Oct; 165():107370. PubMed ID: 37643511
[TBL] [Abstract] [Full Text] [Related]
20. Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 Cases.
Kervarrec T; Imbeaud S; Veyer D; Pere H; Puech J; Pekár-Lukacs A; Markiewicz D; Coutts M; Tallet A; Collin C; Berthon P; Bravo IG; Seris A; Jouary T; Macagno N; Touzé A; Cribier B; Battistella M; Calonje E
Am J Surg Pathol; 2023 Oct; 47(10):1077-1084. PubMed ID: 37505796
[TBL] [Abstract] [Full Text] [Related]
[Next]
